Signifier Medical Technologies Announces $49MM Purchase of Existing Shares by Waha Capital, Angelus Sano Ventures and Segulah Medical Acceleration

2 years ago

BOSTON--(BUSINESS WIRE)--Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announced that Waha Capital PJSC (“Waha…

Defence Therapeutics: An Anti-Cancer Solutions Platform Company Advancing Its Versatile Accum Technology

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - March 22, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF)("Defence" or…

WellAir Launches a New Advanced Air Cleaning Device in Europe with Independently Tested Industry Leading 99.9% Effectiveness Against Airborne Pathogens

2 years ago

The Novaerus Defend 400 is a CE marked device that combines WellAir’s patented NanoStrike™ Technology with a triple-stage filtration system…

AlzeCure Gets Two NeuroRestore Abstracts Accepted to Alzheimer’s Conference

2 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / March 22, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical…

Commercialization Start in Italy after Successful Pilot

2 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / March 22, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group (publ.) hereby announces that the partner Remedio…

Nanomerics Receives Further Upfront Payment for Anti-Viral Spray AnQlar(TM)

2 years ago

LONDON, UK / ACCESSWIRE / March 22, 2022 / Nanomerics Ltd., a private speciality pharmaceutical company, today announced the receipt…

PEP Health selected to take part in first-ever AWS Healthcare Accelerator for pioneering UK start-ups

2 years ago

LONDON, UK / ACCESSWIRE / March 21, 2022 / PEP Health - a health technology company using AI to analyse…

COVID-19 Study Links Psychotropic Medication to Increased Risk of Dementia in Older Adults

2 years ago

MANHASSET, N.Y.--(BUSINESS WIRE)--Recent studies have highlighted the connection between coronavirus disease 2019 (COVID-19) infection and the development of dementia. To…

ESO Launches 2022 ESO EMS Index to Track Nationwide Emergency Medical Services Performance Across Key Metrics

2 years ago

Report focuses on key metrics, including stroke assessment documentation and lights and siren usage; provides deeper insight into healthcare disparities…

iTolerance, Inc. Closes $17.1 Million Convertible Note Financing to Advance Development of Innovative Regenerative Medicines for Transplantation Without the Need for Life-Long Immunosuppression

2 years ago

The Company's proprietary biotechnology-derived Strepavidin-FasL fusion protein/biotin-PEG microgel platform technology, iTOL-100, has demonstrated in animal models of Type 1 Diabetes…